MenQuadfi is a vaccine given to people 2 years of age and older to help prevent invasive meningococcal disease (including meningitis) caused by serogroups ___________ of the bacterium N meningitidis. [Select ALL That Apply].
MenQuadfi is a vaccine given to people 2 years of age and older to help prevent invasive meningococcal disease (including meningitis) caused by serogroups A, C, W, and Y of the bacterium N meningitidis.
MenQuadfi does not prevent serogroup B disease.
In the U.S., the Centers for Disease Control and Prevention recommends vaccination against meningococcal disease at 11-12 years of age and a second dose at 16 years of age.
Despite strong public health recommendations, about half of teens have not received the recommended second dose of MenACWY vaccine by 17 years of age, leaving them vulnerable when they are at increased risk for the disease.
Hundreds of cases of vaccine-preventable meningococcal disease (caused by serogroups B, C, W, Y) still occur annually in the U.S. and, despite treatment, one in five survivors suffer from permanent complications such as hearing loss, organ damage, and limb amputations.
The most common side effects following a first dose of MenQuadfi included injection site pain, muscle ache, headache, and tiredness. In adolescents and adults receiving a MenQuadfi booster, similar rates of these reactions were observed.
www.pharmacyexam.com Try our Naplex Questions QBank.